Eupraxia Pharmaceuticals Inc (EPRX : TSX)
Common Stock
$11.21
CAD
-0.48 (-4.11%)
Last updated: 2026-09-14
Get EPRX alerts:
EPRX
Eupraxia Pharmaceuticals Inc
WealthAwesomePerformance
1 Day
-4.11%
1 Week
-3.69%
1 Month
+20.41%
YTD
+7.17%
Key Statistics
Market Cap
$772.40M
52W High
$12.86
52W Low
$7.15
P/E Ratio
-
50 Day MA
$9.47
200 Day MA
$9.93
Beta
1.49
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/14/2026 | $11.66 | $11.71 | $11.13 | $11.21 | $11.21 | 60,468 |
| 9/11/2026 | $11.27 | $11.79 | $11.26 | $11.69 | $11.69 | 132,629 |
| 9/10/2026 | $11.21 | $11.48 | $11.05 | $11.08 | $11.08 | 42,101 |
| 9/9/2026 | $11.33 | $11.52 | $11.05 | $11.09 | $11.09 | 24,843 |
| 9/8/2026 | $11.53 | $11.82 | $11.32 | $11.38 | $11.38 | 74,382 |
| 9/4/2026 | $10.35 | $11.64 | $10.26 | $11.64 | $11.64 | 102,700 |
| 9/3/2026 | $10.34 | $10.52 | $10.12 | $10.36 | $10.36 | 72,917 |
| 9/2/2026 | $8.81 | $10.33 | $8.81 | $10.30 | $10.30 | 127,774 |
| 9/1/2026 | $8.86 | $9.02 | $8.79 | $8.79 | $8.79 | 32,984 |
| 8/31/2026 | $9.95 | $9.95 | $8.78 | $8.97 | $8.97 | 53,094 |
Analyst Price Targets
Based on analyst covering EPRX
Wall Street analysts forecast EPRX stock price to rise 42.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$16.00
+42.7% Upside
Current Price
C$11.21
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on EPRX's historical volatility
30-Day Vol
75.2%
Annualized
90-Day Vol
66.4%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$13.40
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$11.90 | C$9.18 – C$15.42 |
| 60 trading days | C$12.63 | C$8.75 – C$18.23 |
| 90 trading days | C$13.40 | C$8.55 – C$21.01 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Eupraxia Pharmaceuticals Inc
Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need. Its proprietary Diffusphere technology optimizes drug delivery for applications with significant unmet medical need. The company's product portfolio includes EP-104IAR, which is in Phase III clinical trial for the treatment of knee osteoarthritis; EP-104GI that is in Phase II clinical trial for treating eosinophilic esophagitis; and EP-104, which is under preclinical studies for the treatment of gastrointestinal tract, such as eosinophilic esophagitis. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012. Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-56.87M
- Profit Margin
- 0.00%
- ROE (TTM)
- -66.70%
- EPS (Diluted)
- -1.40
- Book Value
- 2.15
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About EPRX
Market movers
Recent TSX movers
Top 1-day gainers — updated from our Canadian movers feed.
EPRX.TO news timeline
15 articles covering EPRX.TO, most recent first
LatestWhy Eupraxia Pharmaceuticals Inc stock surged yesterday
September 2026
August 2026
- Why Eupraxia Pharmaceuticals Inc stock plummeted yesterday
- What's Going On With Eupraxia Pharmaceuticals Inc Stock Wednesday?
- Why Eupraxia Pharmaceuticals Inc stock surged yesterday
- What's Going On With Eupraxia Pharmaceuticals Inc Stock Wednesday?
- Why Eupraxia Pharmaceuticals Inc stock is sliding today
- Why Eupraxia Pharmaceuticals Inc stock is rising today
- Eupraxia Pharmaceuticals Inc EPRX Earnings Beat Estimates by 0.0%
- What's Going On With Eupraxia Pharmaceuticals Inc Stock Wednesday?
- Why Eupraxia Pharmaceuticals Inc stock is sliding today
- Will Eupraxia Pharmaceuticals Inc (EPRX) Beat Earnings Estimates in Its Next Report?